Ancure

Do I have a case?

 

What is Ancure?

What is the problem?

Who is responsible?

What is being done?

What can you do?

FAQs

Breaking news

Resources on the web

Medical information

Frequently Asked Questions

 

  When was Ancure in use?

  How soon after the product was released did Guidand realize there was a problem?

  How many Ancure units are affected?

  What should I do if I was treated with an Ancure unit?

  Is Ancure still on the market?

 



When was Ancure in use?
Ancure was approved by the FDA in 1999. It was recalled in July 2001. If you have an AAA procedure performed between these two dates, you may have received an Ancure unit.


 


 

How soon after the product was released did Guidant realize there was a problem?
That question is difficult to answer. Guidant did not report adverse reactions as required by law.
 



How many Ancure units are affected?
The FDA knows of approximately 2500 defective units, about 1 in every 3 that were used. However, it is possible that more defective units may turn up.

 



What should I do if I was treated with an Ancure unit?
The FDA makes the following recommendations to doctors regarding Ancure:

  1. Stay Informed. Endovascular repair of AAA is a new and evolving technology, and both Ancure® and AneuRx® have undergone changes in design and labeling during the premarket and postmarket phases. Anticipate that there will be changes and improvements as more clinical experience accumulates with this class of devices. We recommend that you carefully follow the device manufacturer's most recent warnings, precautions, and instructions regarding patient selection and device use.

  2. Make sure that all implanted patients are carefully followed, and undergo periodic follow-up imaging. Patients who are unlikely to adhere to the manufacturer's graft follow-up recommendations may be poor candidates for endovascular repair, even if they are otherwise suitable. Problems that are identified through follow-up imaging may be amenable to further endovascular repair (e.g. additional stent placement), or might require conversion to open aneurysm resection.

  3. Report problems you encounter with the use of these devices, as well as adverse events, to the manufacturer and to the FDA. We will only be able to assess the risk/benefit of these devices, as well as their ultimate clinical usefulness, if we have open communication with practitioners who use them.


 

Is Ancure still on the market?
The product was redesigned, implementing some 20 changes that were approved by the FDA. The redesigned product has been approved for use and is back on the market.


 

Do I have a case?
 

Philadelphia Lawyers - Pennsylvania Lawsuits at Monheit Law

Law Offices of Michael Monheit 1368 Barrowdale Road  Rydal, PA  19046
Call Us Toll Free: 866-761-1385  P: 215-840-6573  E: Michael@Monheit.com